Ameritox

State Guidelines for Urine Drug Monitoring

Guidelines and requirements for monitoring patients on chronic opioid therapy vary from state to state. The chart below lists each state’s name and includes a link to the state regulatory agency responsible for producing these guidelines. When available, additional information is included about specifically where to find this information.

Should your state have no specific guidelines or requirements for monitoring patients on chronic opioid therapy, additional information is available within national guidelines and recommendations regarding the use of urine drug monitoring when treating this patient population.

Note: Many state regulatory agencies update and change their requirements frequently. The list below was last updated October 2012.